Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
DisGeNET
DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
| Source | Last Updated |
|---|---|
| DisGeNET | July 29, 2024 |
| Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
|---|---|---|---|---|---|
| C0015302 | External exotoses | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0010606 | Adenoid Cystic Carcinoma | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0009375 | Colonic Neoplasms | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0278595 | Adult Fibrosarcoma | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0006142 | Malignant neoplasm of breast | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0018802 | Congestive heart failure | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0013366 | Dyschondroplasias | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0235974 | Pancreatic carcinoma | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0026760 | Multiple Epiphyseal Dysplasia | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0027707 | Nephritis, Interstitial | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0023487 | Acute Promyelocytic Leukemia | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0026847 | Spinal Muscular Atrophy | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0014742 | Erythema Multiforme | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0085293 | Hepatitis E | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0025202 | melanoma | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0017636 | Glioblastoma | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0085207 | Gestational Diabetes | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0020473 | Hyperlipidemia | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0268393 | Familial Cerebral Amyloid Angiopathy | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0220633 | Uveal melanoma | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0023434 | Chronic Lymphocytic Leukemia | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0029464 | Osteosclerosis | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0020456 | Hyperglycemia | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0041296 | Tuberculosis | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
| C0600327 | Toxic Shock Syndrome | HSPG2 | 3339 | heparan sulfate proteoglycan 2 | P98160 |
